ArticleRomanian journal of ophthalmology
Macular Telangiectasia Type 2 and Unilateral Subfoveal Vitelliform Lesion: A Longitudinal Follow-up By Multimodal Imaging.
Article in Romanian journal of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Macular telangiectasia type 2 (MacTel type 2) is a bilateral, acquired macular disorder that typically manifests in middle-aged individuals. Circular, yellowish subretinal deposits distinguish a vitelliform lesion (VL) and are very rarely observed in conjunction with MacTel type 2. The presence of VL in cases of MacTel type 2 may further contribute to visual deterioration and lead to misdiagnosis. We report the case of a 54-year-old, otherwise healthy man with MacTel type 2 and unilateral VL, in whom the VL lesion progressed to macular atrophy during a three-year follow-up period.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.